Scott R. Florell
( out of 51 reviews )

Scott R. Florell, MD

Languages spoken: English

Clinical Locations

University of Utah Hospital

Dermatology, Area E
801-581-2955

  • Scott Florell, MD is one of four dermatopathologists in the department that analyzes skin biopsies. He uses his clinical and dermatopathology skills to assist our clinicians in diagnosing skin diseases. His main clinical focus I diagnosing and treating patients with skin cancer. Dr. Florell is board certified in anatomic and clinical pathology, dermatology and dermatopathology.

    Specialties

    Board Certification

    American Board of Dermatology (Dermatology)
    American Board of Dermatology (Sub: Dermatopathology)
    American Board of Pathology (Anatomic & Clinical)
    National Board of Medical Examiners

    Patient Rating

    4.8 /5
    ( out of 51 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 20, 2023
    UH HOSPITALS AND CLINICS

    He was thorough, efficient, and friendly.

    September 11, 2023
    UH HOSPITALS AND CLINICS

    Dr. Florell is very thorough and carefully explains procedures.

    July 14, 2023
    UH HOSPITALS AND CLINICS

    Excellent care

    July 08, 2023
    UH HOSPITALS AND CLINICS

    Dr Florell is an excellent physician. He has great clinical skills and is very caring. He listens and communicates well

    July 08, 2023
    UH HOSPITALS AND CLINICS

    Careful and thorough exam, asks good questions, has even better answers to my questions. Excellent bedside manner.

    March 06, 2023
    UH HOSPITALS AND CLINICS

    I consider myself lucky to have Dr. Florell as my dermatologist.

    March 04, 2023
    UH HOSPITALS AND CLINICS

    Very thorough in his assessment

    February 04, 2023
    UH HOSPITALS AND CLINICS

    Dr Florell is an outstanding physician who is very thorough and explains things in terms you can understand.

    January 11, 2023
    UH HOSPITALS AND CLINICS

    Dr Florell is extremely caring. He is very clear and precise in his decision making and including me in the decision process.

    See More Patient Comments

  • Scott Florell, MD is one of four dermatopathologists in the department that analyzes skin biopsies. He uses his clinical and dermatopathology skills to assist our clinicians in diagnosing skin diseases. His main clinical focus I diagnosing and treating patients with skin cancer. Dr. Florell is board certified in anatomic and clinical pathology, dermatology and dermatopathology.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology (Dermatology)
    American Board of Dermatology (Sub: Dermatopathology)
    American Board of Pathology (Anatomic & Clinical)
    National Board of Medical Examiners

    Education history

    Residency Dermatology - University of Utah School of Medicine Resident
    Internal Medicine - University of Utah School of Medicine Intern
    Residency Pathology - University of Utah School of Medicine Resident
    Medicine - University of Nebraska - Omaha M.D.
    Undergraduate Biology - University of Nebraska - Lincoln B.S.

    Selected Publications

    Journal Article

    1. Gociman S, Wada DA, Bowen AR, Florell SR, Ng D, Madigan LM (2023). Young Woman With Annular and Purpuric Plaques in the Setting of High Fevers: Answer. Am J Dermatopathol, 45(5), 344-345.
    2. Gociman S, Wada DA, Bowen AR, Florell SR, Ng D, Madigan LM (2023). Young Woman With Annular and Purpuric Plaques in the Setting of High Fevers: Challenge. Am J Dermatopathol, 45(5), e32-e34.
    3. Wen-Ying Wong E, Pandeya S, Crandall H, Smart T, Dixon M, Boucher KM, Florell SR, Grossman D, Sanchez B (2023). Electrical Impedance Dermography Differentiates Squamous Cell Carcinoma In Situ from Inflamed Seborrheic Keratoses. JID Innov, 3(3), 100194.
    4. Abbott J, Corean J, Snyder AM, Florell SR, Miles R, Stephens D, Wada DA (2023). Folliculocentric lymphocytic hypersensitivity reactions in CLL/SLL patients: A unique clinicopathologic entity amongst non-specific hypersensitivity reactions. Skin Health Dis, 3(3), e208.
    5. Elkeeb DM, Hopkins ZH, Bolender CM, Moreno C, Florell SR, Bowen AR, Vitale P, Zussman J, Duffy K, Grossman D, Secrest AM, Wada DA (2022). A Single-Institution Cohort Study With Nevi of Special Site: Recurrence, Progression to Melanoma, and Patterns of Management. Am J Dermatopathol, 45(1), 28-39.
    6. Abbott J, Beuning C, Seibert AM, Florell SR, Certain L (2022). Mycetomalike Skin Infection Due to Gordonia bronchialis in an Immunocompetent Patient. Cutis, 110(4), E20-E26.
    7. Clark JJ, Snyder AM, Sreekantaswamy SA, Petersen MJ, Lewis BKH, Secrest AM, Florell SR (2021). Dermatologic care of incarcerated patients: A single-center descriptive study of teledermatology and face-to-face encounters. J Am Acad Dermatol, 85(6), 1660-1662.
    8. Okwundu N, Rahman H, Liu T, Florell SR, Boucher KM, Grossman D (2021). A randomized double-blind placebo-controlled trial of oral aspirin for protection of melanocytic nevi against UV-induced DNA damage. Cancer Prev Res (Phila), 15, 129-138.
    9. Jimenez AR, Florell SR, Donigan JM (2021). Encountering Ethylene Vinyl Alcohol in Dimethyl Sulfoxide Embolization Material During Electrodesiccation and Curettage. Dermatol Surg, 47(10), 1405-1406.
    10. Rahman H, Kumar D, Liu T, Okwundu N, Lum D, Florell SR, Burd CE, Boucher KM, VanBrocklin MW, Grossman D (2020). Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo. J Invest Dermatol, 141(1), 132-141.e3.
    11. Varedi A, Rahman H, Kumar D, Catrow JL, Cox JE, Liu T, Florell SR, Boucher KM, Okwundu N, Burnett WJ, VanBrocklin MW, Grossman D (2020). ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma. Pharmaceuticals (Basel), 13(1).
    12. Flores S, Wada DA, Florell SR, Bowen AR (2019). Pretibial Pruritic Papular Dermatitis: A Comprehensive Clinical and Pathologic Review of Cases at a Single Institution. Am J Dermatopathol, 42(1), 16-19.
    13. Gonzalez CD, Florell SR, Bowen AR, Presson AP, Petersen MJ (2019). Histopathologic vasculitis from the periulcer edge: A retrospective cohort study. J Am Acad Dermatol, 81(6), 1353-1357.
    14. Clark JJ, Hawkes JE, Florell SR, Miles RR, Wada DA (2019). Cutaneous T-Cell Acute Lymphoblastic Leukemia and the Expression Pattern of Terminal Deoxynucleotidyl Transferase Immunostaining in Mycosis Fungoides and Spongiotic Dermatitis. Dermatopathology (Basel), 6(3), 182-188.
    15. Frigerio A, Florell SR, Johnson L (2019). Midline Anterior Neck Inclusion Cyst. J Pediatr, 211, 220.
    16. Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR (2012). Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study. J Cutan Pathol, 39(2), 243-50.
    17. Bowen GM, Bowen AR, Florell SR (2011). Lentigo maligna: one size does not fit all. Arch Dermatol, 147(10), 1211-3.
    18. Summers E, Samadashwily G, Florell SR (2011). A unique presentation of an Epstein-Barr virus-associated natural killer/T-cell lymphoproliferative disorder in a white male adolescent. Arch Dermatol, 147(2), 216-20.
    19. Goodson AG, Florell SR, Boucher KM, Grossman D (2010). Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi. J Am Acad Dermatol, 62(4), 591-6.
    20. Chandler W, Zone J, Florell S (2009). C4d immunohistochemical stain is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in bullous pemphigoid. J Cutan Pathol, 36(6), 655-9.
    21. Florell SR, Coffin CM (2009). Diagnostically Challenging Melanocytic Lesions in Children. Pathol Case Rev, 14(3), 85-92.
    22. Florell SR, Smoller BR, Boucher KM, Grossman D, Harris RM, Bowen GM, Leachman SA (2008). Sampling of melanocytic nevi for research purposes: a prospective, pilot study to determine effect on diagnosis. J Am Acad Dermatol, 59(5), 814-21.
    23. Florell SR, Meyer LJ, Boucher KM, Grossman D, Cannon-Albright LA, Harris RM, Samlowski WE, Zone JJ, Leachman SA (2008). Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree. J Invest Dermatol, 128(8), 2122-5.
    24. Florell SR, Thomas J, Grossman D (2007). Predominant formation of heavily pigmented dermal melanocytomas resembling 'animal-type' melanomas in hepatocyte growth factor (C57BL/6 x C3H)F1 mice following neonatal UV irradiation. J Cutan Pathol, 34(9), 667-74.
    25. Wada DA, Perkins SL, Tripp S, Coffin CM, Florell SR (2007). Human herpesvirus 8 and iron staining are useful in differentiating Kaposi sarcoma from interstitial granuloma annulare. Am J Clin Pathol, 127(2), 263-70.
    26. McKenna JK, Florell SR (2007). Cost-effective dynamic telepathology in the Mohs surgery laboratory utilizing iChat AV videoconferencing software. Dermatol Surg, 33(1), 62-8; discussion 68.
    27. Florell SR, Cessna M, Lundell RB, Boucher KM, Bowen GM, Harris RM, Petersen MJ, Zone JJ, Tripp S, Perkins SL (2006). Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates. Am J Clin Pathol, 125(5), 727-36.
    28. Florell SR, Boucher KM, Garibotti G, Astle J, Kerber R, Mineau G, Wiggins C, Noyes RD, Tsodikov A, Cannon-Albright LA, Zone JJ, Samlowski WE, Leachman SA (2005). Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol, 23(28), 7168-77.
    29. Florell SR, Bowen AR, Hanks AN, Murphy KJ, Grossman D (2005). Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi. J Cutan Pathol, 32(1), 45-9.
    30. Florell SR, Meyer LJ, Boucher KM, Porter-Gill PA, Hart M, Erickson J, Cannon-Albright LA, Pershing LK, Harris RM, Samlowski WE, Zone JJ, Leachman SA (2004). Longitudinal assessment of the nevus phenotype in a melanoma kindred. J Invest Dermatol, 123(3), 576-82.
    31. Florell SR, Egan CA, Gregory MC, Zone JJ, Petersen MJ (2001). Eosinophilic fasciitis occurring four weeks after the onset of dialysis in a renal failure patient. J Cutan Med Surg, 5(1), 33-6.

    Case Report

    1. Granger DL, Rosado-Santos H, Lo TS, Florell SR, Shimwella RAT (2020). Functional Impairment of Skin Appendages Due to Peripheral Nerve Involvement by Mycobacterium leprae. Open Forum Infect Dis, 7(10), ofaa419.
    2. Abbott J, Blake J, Secrest AM, Florell SR (2019). Rapidly progressive and fatal case of extragenital cutaneous epithelioid angiosarcoma with visceral involvement. JAAD Case Rep, 6(1), 33-36.
    3. Shah A, Hyngstrom J, Florell SR, Grossman D (2019). Use of the Pigmented Lesion Assay to rapidly screen a patient with numerous clinically atypical pigmented lesions. JAAD Case Rep, 5(12), 1048-1050.

    Letter

    1. Laggis CW, Lamb A, Secrest AM, Ufkes N, Halwani AS, Tao R, Gaffney D, Miles RR, Florell SR, Wada D (2020). Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution. [Letter to the editor]. J Eur Acad Dermatol Venereol, 35(1), e42-e45.
    2. Grossman D, Florell SR, Duffy KL, Bowen GM (2019). Histologic criteria for assessing surgical margins in melanoma in situ. [Letter to the editor]. J Am Acad Dermatol, 82(4), e133-e134.
    3. Florell SR, Meyer LJ, Boucher KM, Hart M, Cannon-Albright LA, Harris RM, Grossman D, Samlowski WE, Zone JJ, Brinton JP, Leachman SA (2005). Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation. [Letter to the editor]. J Invest Dermatol, 125(6), 1310-2.